Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-targeted exosomes for delivery of anticancer drugs

Cancer Letters(2023)10.1016/j.canlet.2023.216093Source: DataRank Database

Tumor-targeted exosomes for delivery of anticancer drugs is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 97 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access97 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 9.02)OA: hybridTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Dhaval Bhavsar,Dongin Kim ORCID,Xiaoyu Ren ORCID,Vassilios I. Sikavitsas ORCID,Anupama Munshi ORCID

Live enrichment

PubMed:36822543 OpenAlex:https://openalex.org/W4321438694

National Cancer Institute

Grant: R01 CA233201

National Cancer Institute

Grant: P30CA225520

National Cancer Institute

Grant: R01 CA167516

National Cancer Institute

Grant: R01 CA254192

U.S. Department of Defense

Grant: HR18-088

U.S. Department of Defense

Grant: W81XWH-19-1-0647

National Institute of General Medical Sciences

Grant: P20 GM103639

National Institute of General Medical Sciences

Grant: RR & DK

FWCI

9.02

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.canlet.2023.216093

publisherhttps://doi.org/10.1016/j.canlet.2023.216093

publisherhttps://api.elsevier.com/content/article/PII:S0304383523000447?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383523000447?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36822543

Fields of Study

Extracellular vesicles in diseaseRNA Interference and Gene DeliveryMicroRNA in disease regulation

MeSH Terms

Antineoplastic AgentsDrug CarriersHumansNeoplasmsDrug Delivery SystemsExosomes

Keywords

ExosomeMicrovesiclesDrug deliveryIn vivoMedicineImmunogenicityDrugLiposomeCancer researchPharmacologyChemistryBiologyImmunologymicroRNAImmune systemBiochemistryBiotechnology

Sustainable Development Goals

SDG 0: Good health and well-being